| Literature DB >> 33482122 |
Anja Irmisch1, Ximena Bonilla2, Stéphane Chevrier3, Kjong-Van Lehmann2, Franziska Singer4, Nora C Toussaint4, Cinzia Esposito5, Julien Mena6, Emanuela S Milani7, Ruben Casanova3, Daniel J Stekhoven4, Rebekka Wegmann6, Francis Jacob8, Bettina Sobottka9, Sandra Goetze7, Jack Kuipers10, Jacobo Sarabia Del Castillo5, Michael Prummer4, Mustafa A Tuncel10, Ulrike Menzel11, Andrea Jacobs3, Stefanie Engler3, Sujana Sivapatham3, Anja L Frei9, Gabriele Gut5, Joanna Ficek2, Nicola Miglino12, Rudolf Aebersold6, Marina Bacac13, Niko Beerenwinkel10, Christian Beisel11, Bernd Bodenmiller14, Reinhard Dummer1, Viola Heinzelmann-Schwarz15, Viktor H Koelzer9, Markus G Manz12, Holger Moch9, Lucas Pelkmans5, Berend Snijder16, Alexandre P A Theocharides12, Markus Tolnay17, Andreas Wicki18, Bernd Wollscheid7, Gunnar Rätsch19, Mitchell P Levesque20.
Abstract
The application and integration of molecular profiling technologies create novel opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an observational trial combining a prospective diagnostic approach to assess the relevance of in-depth tumor profiling to support clinical decision-making with an exploratory approach to improve the biological understanding of the disease.Entities:
Year: 2021 PMID： 33482122 DOI： 10.1016/j.ccell.2021.01.004
Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743